John D Quisel Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

John D Quisel is Chief Executive Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 72,065 shares of GMTX, which is worth approximately $1.76 Million. The most recent transaction as insider was on Jul 08, 2024, when has been sold 3,000 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $3,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.1K
0% 3M change
n/a 12M change
Total Value Held $1.76 Million

John D Quisel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2024
BUY
Exercise of conversion of derivative security
$3,030 $1.01 p/Share
3,000 Added 4.0%
72,065 Common Stock
Jan 10 2024
BUY
Grant, award, or other acquisition
-
66,365 Added 49.0%
69,065 Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$2,727 $1.01 p/Share
2,700 Added 50.0%
2,700 Common Stock

Also insider at

GOSS
Gossamer Bio, Inc. Healthcare
Director
JDQ

John D Quisel

Chief Executive Officer
Watertown, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX